| Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth | 06/25 14:43 | benzinga.com |
| Keros Therapeutics Announces Leadership Updates | 06/17 16:01 | globenewswire.com |
| Keros Therapeutics Presents Clinical Data from its Elritercept (KER-050) Program at the 29th Annual Hybrid Congress of the European Hematology Association | 06/17 06:00 | globenewswire.com |
| Keros Therapeutics: Potential Beyond KER-050 For Targeting Of Blood Cancers | 06/10 12:48 | seekingalpha.com |
| Keros Therapeutics Appoints Jean-Jacques Bienaimé to its Board of Directors | 05/28 16:01 | globenewswire.com |
| Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association | 05/14 10:00 | globenewswire.com |
| Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results | 05/08 08:00 | globenewswire.com |
| Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference | 03/05 08:00 | globenewswire.com |
| Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results | 02/28 16:01 | globenewswire.com |
| Keros Therapeutics, Inc. (KROS) is on the Move, Here's Why the Trend Could be Sustainable | 02/28 09:51 | zacks.com |